A Phase II Study of Twice Weekly Paclitaxel, Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid in the Treatment of Recurrent or Metastatic Esophageal Cancer
The primary objective of this study is to find out the response rate of twice weekly
paclitaxel and cisplatin and weekly HDFL in recurrent or metastatic esophageal carcinoma
patients who need palliative Chemotherapy. The secondary objectives include overall
survival, progression-free survival, and toxicity.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Response rate
Ann-Lii Cheng, M.D., Ph.D.
Study Chair
Department of Oncology, National Taiwan University hospital
Taiwan: Department of Health
159I9
NCT00154700
January 2001
July 2005
Name | Location |
---|